-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Initiates Coverage On Century Therapeutics with Outperform Rating, Announces Price Target of $8

Benzinga·05/27/2026 09:45:06
Listen to the news
Mizuho analyst Salim Syed initiates coverage on Century Therapeutics (NASDAQ:IPSC) with a Outperform rating and announces Price Target of $8.